The FTIR spectral “diagnostic bands” support the hypothesis that MET protects T2D patients and reacts directly with SARS-CoV-2 spike protein via H-bonds, as schematically presented in Figure 3. The gene discussed is PROS1; the disease is type 2 diabetes mellitus.